![Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra) Metwali HH, Aseeri MA, Mahmoud A, Alsaeed AS, Albdelwahab ME, Salam A, Abulezz R - J Appl Hematol Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra) Metwali HH, Aseeri MA, Mahmoud A, Alsaeed AS, Albdelwahab ME, Salam A, Abulezz R - J Appl Hematol](https://www.jahjournal.org/articles/2016/7/4/images/JApplHematol_2016_7_4_131_198518_t1.jpg)
Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra) Metwali HH, Aseeri MA, Mahmoud A, Alsaeed AS, Albdelwahab ME, Salam A, Abulezz R - J Appl Hematol
![Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism | NEJM Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2003/nejm_2003.349.issue-18/nejmoa035451/production/images/img_medium/nejmoa035451_t2.jpeg)
Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism | NEJM
![These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION.FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION.FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=1509.jpg&id=534616)